Back
Pacira BioSciences Stock Predictions
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
30
PCRX
Pacira BioSciences
Last Price:
$25.13
Seasonality Move:
0.52%
7 Day Trial
ALL ACCESS PASS
$
7
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.Pacira BioSciences Stock Forecast
-
Over the next 52 weeks, Pacira BioSciences has on average historically risen by 18.2% based on the past 14 years of stock performance.
-
Pacira BioSciences has risen higher in 8 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
-
Is Pacira BioSciences Stock Undervalued?The current Pacira BioSciences [PCRX] share price is $25.12. The Score for PCRX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
PCRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Pacira BioSciences Stock Go Up Next Year?
-
Over the next 52 weeks, Pacira BioSciences has on average historically risen by 18.2% based on the past 14 years of stock performance.
Pacira BioSciences Stock Rating
Sell
30
Pacira BioSciences (PCRX)
is a Sell
Is Pacira BioSciences overpriced?
-
Pacira BioSciences has risen higher in 8 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
Pacira BioSciences Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
pacira.com
52-Week Data
52-Week High:
31.67
52-Week Low:
11.16
Prediction Charts
Market Cap:
1.2B
Price in USD:
25.12
Volume:
2.2M
Beta:
0.99
Technical Analysis
SMA50:
24.66
SMA100:
23.69
SMA200:
20.06
52-Wk Change:
-15.87%
Stock Predictions
-
Is Pacira BioSciences stock public?Yes, Pacira BioSciences is a publicly traded company.
-
What is the Pacira BioSciences stock quote today?The Pacira BioSciences stock price is 25.12 USD today.
-
How to buy Pacira BioSciences stock online?You can buy Pacira BioSciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-22 | 26.01 | 25.45 | 26.36 | 25.18 |
| Apr-23 | 25.67 | 25.20 | 26.65 | 25.08 |
| Apr-24 | 25.23 | 26.00 | 26.03 | 25.23 |
| Apr-25 | 25.71 | 25.72 | 26.12 | 25.27 |
| Apr-28 | 25.85 | 27.14 | 27.18 | 25.44 |
| Apr-29 | 27.05 | 27.00 | 27.31 | 26.56 |
| Apr-30 | 26.79 | 26.90 | 27.08 | 26.38 |
| May-1 | 26.66 | 26.75 | 27.13 | 26.34 |
| May-2 | 27.03 | 26.45 | 27.34 | 26.13 |
| May-5 | 26.44 | 25.81 | 26.44 | 25.59 |
| May-6 | 25.77 | 25.15 | 26.30 | 24.94 |
| May-7 | 25.26 | 25.18 | 25.40 | 24.83 |
| May-8 | 25.02 | 24.91 | 25.31 | 24.23 |
| May-9 | 23.00 | 25.12 | 25.80 | 23.00 |
Pacira BioSciences Earnings
Pacira BioSciences Earnings Report: Per Share Pacira BioSciences Earnings Q1 Q2 Q3 and Q4 last year and next year.
Pacira BioSciences Forecast Revenue Growth
Pacira BioSciences Stock Analysis: Historical quarterly revenues per share for Pacira BioSciences and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.16 per share, a decrease this year of $0.35 per share, and an increase next year of $0.66 per share.
* Pacira BioSciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.